Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4176)
All Articles published online
|
May 28, 2012 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang J, Jin MS, Suo J, Wang YP, He L, Cao XY. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. World J Gastroenterol 2012; 18(20): 2569-2575 [PMID: 22654456 DOI: 10.3748/wjg.v18.i20.2569] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i20/2569.htm |
| Number | Citing Articles |
| 1 |
Chengyu Sun, Enguo Fan, Luqiao Huang, Zhengguo Zhang. Performance of radiomics in preoperative determination of malignant potential and Ki-67 expression levels in gastrointestinal stromal tumors: a systematic review and meta-analysis. Acta Radiologica 2024; 65(11): 1307 doi: 10.1177/02841851241285958
|
| 2 |
Tadashi Kondo. Proteogenomics. Advances in Experimental Medicine and Biology 2016; 926: 139 doi: 10.1007/978-3-319-42316-6_9
|
| 3 |
Duraisamy Ramachandhiran, Veerasamy Vinothkumar, Sukumar Babukumar. Paeonol exhibits anti-tumor effects by apoptotic and anti-inflammatory activities in 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis. Biotechnic & Histochemistry 2019; 94(1): 10 doi: 10.1080/10520295.2018.1493221
|
| 4 |
Arnaud Uguen, Gwenaël Conq, Laurent Doucet, Matthieu Talagas, Sebastian Costa, Marc De Braekeleer, Pascale Marcorelles. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors. Virchows Archiv 2015; 467(1): 47 doi: 10.1007/s00428-015-1763-2
|
| 5 |
Michaela Angelika Ihle, Sebastian Huss, Wiebke Jeske, Wolfgang Hartmann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Reinhard Büttner, Harri Sihto, Kirsten Sundby Hall, Mikael Eriksson, Peter Reichardt, Heikki Joensuu, Eva Wardelmann, Anette Duensing. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLOS ONE 2018; 13(2): e0193048 doi: 10.1371/journal.pone.0193048
|
| 6 |
Jun-Chuan Li, Hong-Yu Zhu, Ting-Xuan Chen, Lan-Ying Zou, Xiao-Yan Wang, Hui-Chuan Zhao, Jun Xu. Roles of mTOR and p-mTOR in Gastrointestinal Stromal Tumors. Asian Pacific Journal of Cancer Prevention 2013; 14(10): 5925 doi: 10.7314/APJCP.2013.14.10.5925
|
| 7 |
Chen Li, Ke-Lu Yang, Quan Wang, Jin-Hui Tian, Yang Li, Zhi-Dong Gao, Xiao-Dong Yang, Ying-Jiang Ye, Ke-Wei Jiang. Clinical features of multiple gastrointestinal stromal tumors: A pooling analysis combined with evidence and gap map. World Journal of Gastroenterology 2020; 26(47): 7550-7567 doi: 10.3748/wjg.v26.i47.7550
|
| 8 |
Yu Zhou, Wenqing Hu, Ping Chen, Masanobu Abe, Lei Shi, Si-yuan Tan, Yong Li, Liang Zong. Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors. Medicine 2017; 96(34): e7911 doi: 10.1097/MD.0000000000007911
|
| 9 |
N. Iorio, R. A. Sawaya, F. K. Friedenberg. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours. Alimentary Pharmacology & Therapeutics 2014; 39(12): 1376 doi: 10.1111/apt.12761
|
| 10 |
Ji Li, An-Ran Wang, Xiao-Dong Chen, Hong Pan, Shi-Qiang Li. Ki67 for evaluating the prognosis of gastrointestinal stromal tumors: A systematic review and meta‑analysis. Oncology Letters 2022; 23(6) doi: 10.3892/ol.2022.13309
|
| 11 |
Yongwei Xu, Bacui Zhang, Jing Wang. Gastrointestinal Stromal Tumour with Liver Metastasis Presenting as Gastric Cancer. Diagnostics 2023; 13(3): 376 doi: 10.3390/diagnostics13030376
|
| 12 |
Newton A C S Wong, Jenny Wingate, Elise Gradhand. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild‐type gastrointestinal stromal tumours. Histopathology 2015; 67(3): 378 doi: 10.1111/his.12667
|
| 13 |
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. International Journal of Molecular Sciences 2021; 22(2): 493 doi: 10.3390/ijms22020493
|
| 14 |
Heikki Joensuu, Peter Hohenberger, Christopher L Corless. Gastrointestinal stromal tumour. The Lancet 2013; 382(9896): 973 doi: 10.1016/S0140-6736(13)60106-3
|
| 15 |
Cai-Wei Yang, Xi-Jiao Liu, Si-Yun Liu, Shang Wan, Zheng Ye, Bin Song, Jian-Guo Zhou. Current and Potential Applications of Artificial Intelligence in Gastrointestinal Stromal Tumor Imaging. Contrast Media & Molecular Imaging 2020; 2020: 1 doi: 10.1155/2020/6058159
|
| 16 |
Erika P. Berger, Chad M. Johannes, Albert E. Jergens, Karin Allenspach, Barbara E. Powers, Yingzhou Du, Jonathan P. Mochel, Leslie E. Fox, Margaret L. Musser. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs. Journal of Veterinary Internal Medicine 2018; 32(6): 2045 doi: 10.1111/jvim.15335
|
| 17 |
Lin Xiao, Yiding Zhang, Yajie Wang, Lede Liu, Yisheng Pan. The relationship between Ki-67 expression and imaging signs and pathological features in GISTs. Frontiers in Surgery 2023; 10 doi: 10.3389/fsurg.2023.1095924
|
| 18 |
Nurten Turkel Kucukmetin, Bahattin Cicek, Murat Saruc, Ozdal Ersoy, Eser Vardareli, Oguz Onder, Ercument Gurluler, Arzu Tiftikci, Suha Goksel, Nurdan Tozun. Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1276 doi: 10.1097/MEG.0000000000000454
|
| 19 |
Heikki Joensuu. Gastrointestinal Stromal Tumors. Hematology/Oncology Clinics of North America 2013; 27(5): 889 doi: 10.1016/j.hoc.2013.07.004
|
| 20 |
Chiao-En Wu, Chiao-Ping Chen, Wen-Kuan Huang, Yi-Ru Pan, Erhan Aptullahoglu, Chun-Nan Yeh, John Lunec. p53 as a biomarker and potential target in gastrointestinal stromal tumors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.872202
|
| 21 |
Ugne Gyvyte, Rokas Lukosevicius, Ruta Inciuraite, Greta Streleckiene, Greta Gudoityte, Justina Bekampyte, Serena Valentini, Violeta Salteniene, Paulius Ruzgys, Saulius Satkauskas, Kristina Zviniene, Juozas Kupcinskas, Jurgita Skieceviciene. The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors. International Journal of Molecular Sciences 2020; 21(14): 5151 doi: 10.3390/ijms21145151
|
| 22 |
Shan‐Shan Shi, Nan Wu, Yan He, Xue Wei, Qiu‐Yuan Xia, Xuan Wang, Sheng‐Bin Ye, Rui Li, Qiu Rao, Xiao‐Jun Zhou. EGFR gene mutation in gastrointestinal stromal tumours. Histopathology 2017; 71(4): 553 doi: 10.1111/his.13251
|
| 23 |
Qing‐Wei Zhang, Yun‐Jie Gao, Ran‐Ying Zhang, Xiao‐Xuan Zhou, Shuang‐Li Chen, Yan Zhang, Qiang Liu, Jian‐Rong Xu, Zhi‐Zheng Ge. Personalized CT‐based radiomics nomogram preoperative predicting Ki‐67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort. Clinical and Translational Medicine 2020; 9(1) doi: 10.1186/s40169-020-0263-4
|
| 24 |
Sarra Ben Rejeb, Dorra Aloui, Asma Ayari, Adnen Chouchen. Prognostic Significance of C-MYC and EGFR Overexpression in Gastrointestinal Stromal Tumors: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology 2024; doi: 10.1097/PAI.0000000000001235
|